Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Cao

Showing results (91-100 of 143) with videos related to

Pageof 15
Sort By:
Journal of Thrombosis and Thrombolysis|March 12, 2021
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studiesToshiki Kuno, Bimmer Claessen, Davide Cao, et al.
Journal of Thrombosis and Thrombolysis|August 4, 2021
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarctionJohny Nicolas, Frans Beerkens, Davide Cao, et al.
ESC Heart Failure|June 30, 2022
Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysisMauro Chiarito, Jorge Sanz-Sanchez, Michele Pighi, et al.
CJC Open|July 23, 2020
Residual SYNTAX Score and One-Year Outcome in Elderly Patients With Acute Coronary SyndromeNuccia Morici, Gianfranco Alicandro, Luca A Ferri, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 10, 2023
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trialDaniel Feldman, Davide Cao, Samantha Sartori, et al.
International Journal of Cardiology|October 22, 2019
Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trialRidhima Goel, David Power, Didier Tchetche, et al.
The American Journal of Cardiology|June 24, 2023
Percutaneous Coronary Intervention in Men, Women, and Minorities With a Previous Coronary Artery Bypass Graft Surgery (from the Pooled PLATINUM Diversity and PROMUS Element Plus Registries)Frans J Beerkens, Davide Cao, Wayne Batchelor, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 7, 2022
Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCIDavide Cao, Julie A Swain, Samantha Sartori, et al.
European Heart Journal. Acute Cardiovascular Care|July 17, 2023
Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS studyMauro Chiarito, Davide Cao, Samantha Sartori, et al.
Journal of the American Heart Association|April 1, 2020
Sex-Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient-Level Pooled Analysis From 4 Postapproval StudiesRishi Chandiramani, Davide Cao, Bimmer E Claessen, et al.
Pageof 15

Showing results (91-100 of 143) with videos related to

Sort By:
Pageof 15
Journal of Thrombosis and Thrombolysis|March 12, 2021
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studiesToshiki Kuno, Bimmer Claessen, Davide Cao, et al.
Journal of Thrombosis and Thrombolysis|August 4, 2021
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarctionJohny Nicolas, Frans Beerkens, Davide Cao, et al.
ESC Heart Failure|June 30, 2022
Edge-to-edge percutaneous mitral repair for functional ischaemic and non-ischaemic mitral regurgitation: a systematic review and meta-analysisMauro Chiarito, Jorge Sanz-Sanchez, Michele Pighi, et al.
CJC Open|July 23, 2020
Residual SYNTAX Score and One-Year Outcome in Elderly Patients With Acute Coronary SyndromeNuccia Morici, Gianfranco Alicandro, Luca A Ferri, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 10, 2023
Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trialDaniel Feldman, Davide Cao, Samantha Sartori, et al.
International Journal of Cardiology|October 22, 2019
Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trialRidhima Goel, David Power, Didier Tchetche, et al.
The American Journal of Cardiology|June 24, 2023
Percutaneous Coronary Intervention in Men, Women, and Minorities With a Previous Coronary Artery Bypass Graft Surgery (from the Pooled PLATINUM Diversity and PROMUS Element Plus Registries)Frans J Beerkens, Davide Cao, Wayne Batchelor, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|April 7, 2022
Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCIDavide Cao, Julie A Swain, Samantha Sartori, et al.
European Heart Journal. Acute Cardiovascular Care|July 17, 2023
Thrombotic risk in patients with acute coronary syndromes discharged on prasugrel or clopidogrel: results from the PROMETHEUS studyMauro Chiarito, Davide Cao, Samantha Sartori, et al.
Journal of the American Heart Association|April 1, 2020
Sex-Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient-Level Pooled Analysis From 4 Postapproval StudiesRishi Chandiramani, Davide Cao, Bimmer E Claessen, et al.
Pageof 15